Clinical and non-invasive genetic study of first six Croatian patients with dysferlinopathy (CROSBI ID 523130)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Canki-Klain, Nina ; Milić, Astrid ; Malnar, Martina
engleski
Clinical and non-invasive genetic study of first six Croatian patients with dysferlinopathy
Mutations in the human dysferlin (DYSF) gene cause autosomal recessive muscular dystrophies characterized by degeneration and weakness of proximal and/or distal muscles: limb girdle muscular dystrophy 2B and Miyoshi myopathy (MM). Current diagnostic methods require muscle biopsy for immunodiagnosis, followed by direct gene analysis. Aim. To present an alternative, non-invasive approach to diagnosis based on linkage analysis and a non-invasive blood diagnostic assay. Patients and Methods. Six patients from five unrelated, informative, Croatian families affected by presumed MM/LGMD2B were selected on clinical and laboratory features. Haplotype analysis was done by microsatellites flanking the dysferlin gene: D2S292, D2S2113, D2S291 and D2S2111. Non-invasive diagnostics of dysferlin from peripheral blood used the new method (Ho M et al. Ann Neurol 2001 ; 51:129-133) consisted in: Isolation of peripheral blood mononuclear cells (PBMC) by Ficoll and CD14MicroBeads followed by SDS-PAGE and immunoblotting using the NCL-Hamlet anti-dysferlin monoclonal antibody. Immunoreactive bands were detected with chemiluminiscence system (Amersham). Results. All six patients showed linkage with studied markers. Moreover, three MM patients from two families showed two different homozygous haplotypes suggesting homozygosity of one or two mutations of independent origin. Immunoblotting of dysferlin on PBMC and skeletal muscle was detected in controls, but was absent in four and weak in two patients. These preliminary results need direct detection of gene mutation. Conclusion. Since we lack sensitive and specific biopsy screening methods for detecting patients with dysferlinopathy, linkage analysis in informative families followed by Western blot analysis of dysferlin on PBMC could avoid the need of invasive procedure for muscle specimens.
dysferlinopathy; LGMD2B; clinics; linkage analysis; Western blot; monocytes
doi:10.1016/j.nmd.2005.06.006
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
691-692.
2005.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
International Congress of the World Muscle Society (10 ; 2005)
poster
25.09.2005-01.10.2005
slapovi Iguaçu, Brazil
Povezanost rada
Kliničke medicinske znanosti, Biologija